217 related articles for article (PubMed ID: 35299842)
1. Roles of Pyroptosis-Related Gene Signature in Prediction of Endometrial Cancer Outcomes.
Chen Y; Liao Y; Du Q; Shang C; Qin S; Lee K; Zou Q; Liu J; Yao S
Front Med (Lausanne); 2022; 9():822806. PubMed ID: 35299842
[TBL] [Abstract][Full Text] [Related]
2. A Cholesterol Homeostasis-Related Gene Signature Predicts Prognosis of Endometrial Cancer and Correlates With Immune Infiltration.
Chen Y; Lee K; Liang Y; Qin S; Zhu Y; Liu J; Yao S
Front Genet; 2021; 12():763537. PubMed ID: 34790227
[No Abstract] [Full Text] [Related]
3. Identification of a pyroptosis-related prognostic signature in breast cancer.
Chen H; Luo H; Wang J; Li J; Jiang Y
BMC Cancer; 2022 Apr; 22(1):429. PubMed ID: 35443644
[TBL] [Abstract][Full Text] [Related]
4. Pyroptosis-Related Gene Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Glioma.
Zhang Y; Zhang C; Yang Y; Wang G; Wang Z; Liu J; Zhang L; Yu Y
Front Cell Dev Biol; 2022; 10():862493. PubMed ID: 35547808
[No Abstract] [Full Text] [Related]
5. A Novel Defined Pyroptosis-Related Gene Signature for Predicting the Prognosis of Endometrial Cancer.
Liu S; Zeng C; Lv H; Zhang Y; Xiong H; Tang H
Dis Markers; 2022; 2022():7570494. PubMed ID: 36601599
[TBL] [Abstract][Full Text] [Related]
6. A novel risk prediction model of pyroptosis-related genes for the prognosis and immunotherapy response of endometrial cancer.
Liu ZS; Jing CL
Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2259-2278. PubMed ID: 35442481
[TBL] [Abstract][Full Text] [Related]
7. Construction and validation of a pyroptosis-related gene signature associated with the tumor microenvironment in uveal melanoma.
Zhang F; Deng Y; Wang D; Wang S
Sci Rep; 2022 Jan; 12(1):1640. PubMed ID: 35102195
[TBL] [Abstract][Full Text] [Related]
8. Identification and Validation of Pyroptosis-Related Gene Signature to Predict Prognosis and Reveal Immune Infiltration in Hepatocellular Carcinoma.
Fu XW; Song CQ
Front Cell Dev Biol; 2021; 9():748039. PubMed ID: 34820376
[No Abstract] [Full Text] [Related]
9. Identification of a Pyroptosis-Related Gene Signature for Predicting Overall Survival and Response to Immunotherapy in Hepatocellular Carcinoma.
Zheng S; Xie X; Guo X; Wu Y; Chen G; Chen X; Wang M; Xue T; Zhang B
Front Genet; 2021; 12():789296. PubMed ID: 34925465
[TBL] [Abstract][Full Text] [Related]
10. A Pyroptosis-Related Gene Panel in Prognosis Prediction and Immune Microenvironment of Human Endometrial Cancer.
Zhang X; Yang Q
Front Cell Dev Biol; 2021; 9():705828. PubMed ID: 34722500
[TBL] [Abstract][Full Text] [Related]
11. Construction of Pyroptosis-Related Prognostic and Immune Infiltration Signature in Bladder Cancer.
Du X; Zhao X; Tang Y; Tang W
Dis Markers; 2022; 2022():6429993. PubMed ID: 36569221
[TBL] [Abstract][Full Text] [Related]
12. Combination of ferroptosis and pyroptosis to construct a prognostic classifier and predict immune landscape, chemotherapeutic efficacy and immunosuppressive molecules in hepatocellular carcinoma.
Xu L; Zheng Q; Liu W
BMC Cancer; 2022 Mar; 22(1):229. PubMed ID: 35236323
[TBL] [Abstract][Full Text] [Related]
13. A Novel Risk Signature with Seven Pyroptosis-Related Genes for Prognosis Prediction in Glioma.
Huang Q; Li J; Mo L; Zhao Y
World Neurosurg; 2022 Mar; 159():e285-e302. PubMed ID: 34929369
[TBL] [Abstract][Full Text] [Related]
14. Values of a novel pyroptosis-related genetic signature in predicting outcome and immune status of pancreatic ductal adenocarcinoma.
Xu X; Liang JH; Li JH; Xu QC; Yin XY
Gastroenterol Rep (Oxf); 2022; 10():goac051. PubMed ID: 36196256
[TBL] [Abstract][Full Text] [Related]
15. Construction and validation of a novel pyroptosis-related signature to predict prognosis in patients with cutaneous melanoma.
Niu Z; Xu Y; Li Y; Chen Y; Han Y
Math Biosci Eng; 2022 Jan; 19(1):688-706. PubMed ID: 34903008
[TBL] [Abstract][Full Text] [Related]
16. Predicting the prognosis in patients with sepsis by a pyroptosis-related gene signature.
Liang S; Xing M; Chen X; Peng J; Song Z; Zou W
Front Immunol; 2022; 13():1110602. PubMed ID: 36618365
[TBL] [Abstract][Full Text] [Related]
17. A novel defined risk signature based on pyroptosis-related genes can predict the prognosis of prostate cancer.
Hu D; Cao Q; Tong M; Ji C; Li Z; Huang W; Jin Y; Tong G; Wang Y; Li P; Zhang H
BMC Med Genomics; 2022 Feb; 15(1):24. PubMed ID: 35135561
[TBL] [Abstract][Full Text] [Related]
18. Construction of a Pyroptosis-Related Signature for Prognostic Prediction and Characterization of Immune Microenvironment in Acute Myelogenous Leukemia.
Liu S; Luo D; Luo J; Liang H; Zhi Y; Wang D; Xu N
Int J Gen Med; 2022; 15():2913-2927. PubMed ID: 35308573
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Pyroptosis-Related Immune Signatures and Identification of Pyroptosis-Related LncRNA Prognostic Signature in Clear Cell Renal Cell Carcinoma.
Zhong M; Wang X; Zhu E; Gong L; Fei L; Zhao L; Wu K; Tang C; Zhang L; Wang Z; Zheng Z
Front Genet; 2022; 13():905051. PubMed ID: 35846134
[TBL] [Abstract][Full Text] [Related]
20. A Pyroptosis-Related Gene Panel for Predicting the Prognosis and Immune Microenvironment of Cervical Cancer.
Hu H; Yang M; Dong W; Yin B; Ding J; Huang B; Zheng Q; Li F; Han L
Front Oncol; 2022; 12():873725. PubMed ID: 35574296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
